Polarean Imaging is a medical drug-device company that specializes in helping existing MRI systems to achieve a higher level of pulmonary imaging. The company focuses on developing and commercializing gas polarizer devices and ancillary instruments, with a particular focus on the use of polarized Xenon gas for imaging purposes. Through the use of this gas, Polarean Imaging is able to provide detailed images of the respiratory system, including visualization of the smallest airways of the lungs, the tissue barrier between the lung and bloodstream, and the pulmonary vasculature. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are an essential component for imaging 129Xe in the MRI system. Polarean Imaging was founded in 2016 and is headquartered in Durham, North Carolina.